Naprosyn and Drug ineffective - a phase IV clinical study of FDA data
Summary:
Drug ineffective is found among people who take Naprosyn, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Naprosyn and have Drug ineffective. It is created by eHealthMe based on reports of 15,552 people who have side effects when taking Naprosyn from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
15,552 people reported to have side effects when taking Naprosyn.
Among them, 2,409 people (15.49%) have Drug ineffective.
What is Naprosyn?
Naprosyn has active ingredients of naproxen. It is often used in pain. eHealthMe is studying from 15,944 Naprosyn users for its effectiveness, alternative drugs and more.
What is Drug ineffective?
Drug ineffective is found to be associated with 4,350 drugs and 4,999 conditions by eHealthMe.
Number of Naprosyn and Drug ineffective reports submitted per year:
Time on Naprosyn when people have Drug ineffective *:
Gender of people who have Drug ineffective when taking Naprosyn*:
Age of people who have Drug ineffective when taking Naprosyn *:
Common drugs people take besides Naprosyn *:
Common side effects people have besides Drug ineffective *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Naprosyn and have Drug ineffective?
Check whether Drug ineffective is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Drug ineffective and when was it recovered:
Expand to all the drugs that have ingredients of naproxen:
- Drug ineffective and drugs with ingredients of naproxen (9,680 reports)
Alternative drugs to, pros and cons of Naprosyn:
- Naprosyn (15,944 reports)
Common Naprosyn side effects:
- Drug ineffective: 2,409 reports
- Pain: 2,031 reports
- Joint pain: 1,456 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 1,396 reports
- Fatigue (feeling of tiredness): 1,358 reports
- Headache (pain in head): 1,319 reports
- Dizziness: 1,293 reports
Browse all side effects of Naprosyn:
a b c d e f g h i j k l m n o p q r s t u v w x y zDrug ineffective treatments and more:
- Drug ineffective (1,151,479 reports)
COVID vaccines that are related to Drug ineffective:
- Drug ineffective in Moderna COVID Vaccine
- Drug ineffective in Pfizer BioNTech Covid Vaccine
- Drug ineffective in Johnson and Johnson Covid Vaccine
Common drugs associated with Drug ineffective:
- Methotrexate: 104,668 reports
- Humira: 93,489 reports
- Enbrel: 90,931 reports
- Prednisone: 66,683 reports
- Xeljanz: 48,562 reports
- Orencia: 47,976 reports
- Adapalene: 45,683 reports
- Actemra: 40,430 reports
- Remicade: 37,128 reports
- Sulfasalazine: 35,158 reports
All the drugs that are associated with Drug ineffective:
- Drug ineffective (4,350 drugs)
Common conditions associated with Drug ineffective:
- Rheumatoid arthritis: 123,880 reports
- Pain: 40,150 reports
- Psoriasis: 33,532 reports
- High blood pressure: 31,954 reports
- Multiple sclerosis: 25,819 reports
- Depression: 24,053 reports
All the conditions that are associated with Drug ineffective:
- Drug ineffective (4,999 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on naproxen (the active ingredients of Naprosyn) and Naprosyn (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bendamustine and Oral Infection - now
- Pancytopenia and drugs of ingredients of tigecycline - now
- Ciprodex and Neck Pain - 3 seconds ago
- Bactrim and Sectral drug interaction - 5 seconds ago
- Ritalin and Apresoline drug interaction - 7 seconds ago
- Copaxone and Sarcoidosis - 9 seconds ago
- Xolair and Sertraline drug interaction - 10 seconds ago
- Tramadol and Genital Ulceration - 13 seconds ago
- Aspirin and Periarthritis - 15 seconds ago
- Cimetidine and Pain - 20 seconds ago